Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)Access to Information: Individual's rights to obtain and use information collected or generated by others.Laboratory Infection: Accidentally acquired infection in laboratory workers.Journal Impact Factor: A quantitative measure of the frequency on average with which articles in a journal have been cited in a given period of time.Periodicals as Topic: A publication issued at stated, more or less regular, intervals.Peer Review, Research: The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions.Adenocarcinoma: A malignant epithelial tumor with a glandular organization.Publishing: "The business or profession of the commercial production and issuance of literature" (Webster's 3d). It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing.Appendiceal Neoplasms: Tumors or cancer of the APPENDIX.Carcinoma, Signet Ring Cell: A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)Adenocarcinoma: A malignant epithelial tumor with a glandular organization.ras Proteins: Small, monomeric GTP-binding proteins encoded by ras genes (GENES, RAS). The protooncogene-derived protein, PROTO-ONCOGENE PROTEIN P21(RAS), plays a role in normal cellular growth, differentiation and development. The oncogene-derived protein (ONCOGENE PROTEIN P21(RAS)) can play a role in aberrant cellular regulation during neoplastic cell transformation (CELL TRANSFORMATION, NEOPLASTIC). This enzyme was formerly listed as EC 3.6.1.47.Receptor, Epidermal Growth Factor: A cell surface receptor involved in regulation of cell growth and differentiation. It is specific for EPIDERMAL GROWTH FACTOR and EGF-related peptides including TRANSFORMING GROWTH FACTOR ALPHA; AMPHIREGULIN; and HEPARIN-BINDING EGF-LIKE GROWTH FACTOR. The binding of ligand to the receptor causes activation of its intrinsic tyrosine kinase activity and rapid internalization of the receptor-ligand complex into the cell.Appendiceal Neoplasms: Tumors or cancer of the APPENDIX.Carcinoma, Signet Ring Cell: A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.Mutation: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.Pseudomyxoma Peritonei: A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma (CYSTADENOCARCINOMA, MUCINOUS), which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. (Segen, Dictionary of Modern Medicine, 1992)Prognosis: A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.Lung Neoplasms: Tumors or cancer of the LUNG.Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)Appendix: A worm-like blind tube extension from the CECUM.Appendiceal Neoplasms: Tumors or cancer of the APPENDIX.Adenocarcinoma: A malignant epithelial tumor with a glandular organization.Pseudomyxoma Peritonei: A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma (CYSTADENOCARCINOMA, MUCINOUS), which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. (Segen, Dictionary of Modern Medicine, 1992)Mucocele: A retention cyst of the salivary gland, lacrimal sac, paranasal sinuses, appendix, or gallbladder. (Stedman, 26th ed)Carcinoma, Signet Ring Cell: A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.Cystadenoma, Mucinous: A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.Appendectomy: Surgical removal of the vermiform appendix. (Dorland, 28th ed)Appendicitis: Acute inflammation of the APPENDIX. Acute appendicitis is classified as simple, gangrenous, or perforated.Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)Adenocarcinoma: A malignant epithelial tumor with a glandular organization.Appendiceal Neoplasms: Tumors or cancer of the APPENDIX.Carcinoma, Signet Ring Cell: A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.DeoxycytidinePseudomyxoma Peritonei: A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma (CYSTADENOCARCINOMA, MUCINOUS), which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. (Segen, Dictionary of Modern Medicine, 1992)Rectal Fistula: An abnormal anatomical passage connecting the RECTUM to the outside, with an orifice at the site of drainage.Cecal Neoplasms: Tumors or cancer of the CECUM.Cystadenoma, Mucinous: A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.Urachal Cyst: Cyst occurring in a persistent portion of the urachus, presenting as an extraperitoneal mass in the umbilical region. It is characterized by abdominal pain, and fever if infected. It may rupture, leading to peritonitis, or it may drain through the umbilicus.Rectal Fistula: An abnormal anatomical passage connecting the RECTUM to the outside, with an orifice at the site of drainage.Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)Adenocarcinoma: A malignant epithelial tumor with a glandular organization.Sigmoid Neoplasms: Tumors or cancer of the SIGMOID COLON.Appendiceal Neoplasms: Tumors or cancer of the APPENDIX.Digestive System Surgical Procedures: Surgery performed on the digestive system or its parts.Carcinoma, Signet Ring Cell: A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.Fistula: Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.Colon, Sigmoid: A segment of the COLON between the RECTUM and the descending colon.Fibrin Tissue Adhesive: An autologous or commercial tissue adhesive containing FIBRINOGEN and THROMBIN. The commercial product is a two component system from human plasma that contains more than fibrinogen and thrombin. The first component contains highly concentrated fibrinogen, FACTOR VIII, fibronectin, and traces of other plasma proteins. The second component contains thrombin, calcium chloride, and antifibrinolytic agents such as APROTININ. Mixing of the two components promotes BLOOD CLOTTING and the formation and cross-linking of fibrin. The tissue adhesive is used for tissue sealing, HEMOSTASIS, and WOUND HEALING.Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)Penile Induration: A condition characterized by hardening of the PENIS due to the formation of fibrous plaques on the dorsolateral aspect of the PENIS, usually involving the membrane (tunica albuginea) surrounding the erectile tissue (corpus cavernosum penis). This may eventually cause a painful deformity of the shaft or constriction of the urethra, or both.Penis: The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra.Adenocarcinoma: A malignant epithelial tumor with a glandular organization.Testis: The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS.Epididymis: The convoluted cordlike structure attached to the posterior of the TESTIS. Epididymis consists of the head (caput), the body (corpus), and the tail (cauda). A network of ducts leaving the testis joins into a common epididymal tubule proper which provides the transport, storage, and maturation of SPERMATOZOA.Impotence, Vasculogenic: Inability to achieve and maintain an erection (ERECTILE DYSFUNCTION) due to defects in the arterial blood flow to the PENIS, defect in venous occlusive function allowing blood drainage (leakage) from the erectile tissue (corpus cavernosum penis), or both.Penile Implantation: Surgical insertion of cylindric hydraulic devices for the treatment of organic ERECTILE DYSFUNCTION.Penile Prosthesis: Rigid, semi-rigid, or inflatable cylindric hydraulic devices, with either combined or separate reservoir and pumping systems, implanted for the surgical treatment of organic ERECTILE DYSFUNCTION.Urologic Surgical Procedures, Male: Surgery performed on the male genitalia.Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)Fallopian Tubes: A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.Adenocarcinoma: A malignant epithelial tumor with a glandular organization.Adnexal Diseases: Diseases of the uterine appendages (ADNEXA UTERI) including diseases involving the OVARY, the FALLOPIAN TUBES, and ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT).Fallopian Tube Neoplasms: Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.Pathology, Oral: A dental specialty concerned with pathology of the oral cavity.Appendiceal Neoplasms: Tumors or cancer of the APPENDIX.Carcinoma, Signet Ring Cell: A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.Mammography: Radiographic examination of the breast.Pseudomyxoma Peritonei: A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma (CYSTADENOCARCINOMA, MUCINOUS), which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. (Segen, Dictionary of Modern Medicine, 1992)Salivary Gland Neoplasms: Tumors or cancer of the SALIVARY GLANDS.Lymphoma, B-Cell, Marginal Zone: Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.Salivary Glands: Glands that secrete SALIVA in the MOUTH. There are three pairs of salivary glands (PAROTID GLAND; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND).Carcinoma, Adenoid Cystic: Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed)Salivary Glands, Minor: Accessory salivary glands located in the lip, cheek, tongue, floor of mouth, palate and intramaxillary.Parotid Gland: The largest of the three pairs of SALIVARY GLANDS. They lie on the sides of the FACE immediately below and in front of the EAR.Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.Rhinoscleroma: A granulomatous disease caused by KLEBSIELLA RHINOSCLEROMATIS infection. Despite its name, this disease is not limited to the nose and NASOPHARYNX but may affect any part of the RESPIRATORY TRACT, sometimes with extension to the lip and the skin.Submandibular Gland NeoplasmsMikulicz' Disease: A chronic, benign, and usually painless inflammatory swelling of the lacrimal and salivary glands. It is considered by some to include the glandular enlargement associated with other diseases, such as Sjogren's syndrome, sarcoidosis, lupus erythematosus, etc.
(1/804) Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.

The primary element in the cAMP signal transduction pathway is the cAMP-dependent protein kinase (PKA). Expression of the RIalpha subunit of type I PKA is elevated in a variety of human tumours and cancer cell lines. The purpose of this study was to assess the prognostic importance of RIalpha expression in patients with ovarian cancer. We have evaluated the expression of RIalpha in a panel of human ovarian tumours (n = 40) and five human ovarian cancer cell lines using quantitative reverse transcription polymerase chain reaction (RT-PCR) and Western blot analysis. The human ovarian cell lines OAW42 and OTN14 express high endogenous levels of RIalpha mRNA and protein (at significantly higher mRNA levels than high tissue expressors, P < 0.05). The ovarian cell line A2780 expresses low endogenous levels of RIalpha mRNA and protein (also at higher mRNA levels than low tissue expressors, P < 0.05). Quantitative RT-PCR revealed no significant difference in RIalpha mRNA expression between different ovarian histological subtypes in this study. No associations were found between RIalpha mRNA expression and differentiation state. RIalpha mRNA expression was significantly associated with tumour stage (P = 0.0036), and this remained significant in univariate analysis (P = 0.0002). A trend emerged between RIalpha mRNA expression levels and overall survival in univariate analysis (P = 0.051), however, by multivariate analysis, stage remained the major determinant of overall survival (P = 0.0001). This study indicates that in ovarian epithelial tumours high RIalpha mRNA expression is associated with advanced stage disease. RIalpha expression may be of predictive value in ovarian cancer and may be associated with dysfunctional signalling pathways in this cancer type.  (+info)

(2/804) Combined inhibin and CA125 assays in the detection of ovarian cancer.

BACKGROUND: The reproductive hormone inhibin has been used as a diagnostic marker of ovarian mucinous and granulosa cell cancers. The aims of this study were to develop a new inhibin immunofluorometric assay (alphaC IFMA) to replace an inhibin RIA as a diagnostic marker of these ovarian cancers and to assess whether the alphaC IFMA in combination with CA125, which detects serous cancers, leads to an improved biochemical diagnosis of all ovarian cancers. METHODS: Serum inhibin concentrations were determined in healthy postmenopausal women (n = 165) and women with ovarian cancers (n = 154), using an inhibin RIA and an alphaC IFMA, which detects inhibin forms containing the alphaC subunit as well as the free alphaC subunit. RESULTS: The alphaC IFMA gave a similar or better discrimination of mucinous (90% vs 71%) and granulosa cell (100% vs 100%) cancers compared with the inhibin RIA. Combination of CA125 and alphaC IFMA values by canonical variate analysis or by multiROC analysis showed that the percentage of all ovarian cancers detected was significantly increased compared with either CA125 or alphaC IFMA alone. CONCLUSIONS: The alphaC IFMA shows a similar or better specificity compared with the RIA, but with increased sensitivity. In combination with CA125, the alphaC IFMA provides an effective dual test for the detection of the majority (90%) of ovarian cancers.  (+info)

(3/804) Clinicopathologic characteristics of mucinous gastric adenocarcinoma.

There has been considerable controversy over the prognosis of mucinous gastric adenocarcinoma (MGC). In this study we analyzed the clinicopathologic differences between MGC and non-mucinous gastric carcinoma (NMGC). In addition, the relationship between mucin content and other clinicopathologic variables, including prognosis in MGC, was also investigated. We reviewed 2118 patients with pathologically-confirmed gastric cancer who underwent gastrectomy at the Department of Surgery, Yonsei University College of Medicine, during the period between Jan. 1987 and Dec. 1993. Among them, 130 patients had gastric carcinoma with extracellular mucin (MGC) and 1988 patients had gastric carcinoma without extracellular mucin (NMGC). We placed the MGC patients into two groups according to mucin content: mucin content involving over 50% of the tumor (dominant type, n = 94) and mucin content involving less than 50% of the tumor area (partial type, n = 36). The results were as follows: MGC was more common in males than NMGC. The size of the tumor in MGC (mean 5.3 cm) was larger than that of NMGC (mean 4.4 cm). The patients with MGC had a higher incidence of Borrmann type IV (MGC: 16.1%, NMGC: 9.9%), more frequent serosal invasion (MGC: 75.4%, NMGC: 48.6%), lymph-node metastasis (MGC: 75.4%, NMGC: 50.7%), and peritoneal metastasis (MGC: 10.0%, NMGC: 3.5%) than patients with NMGC. The patients with MGC were more advanced in stage at the time of diagnosis and had a worse overall 10-year survival rate (44.9%) than patients with NMGC (54.7%). However, the 10-year survival rate according to the stage of MGC was similar to that of NMGC. There were no significant differences between the mucin content and other pathologic variables, including prognosis, i.e. similar biologic behavior between dominant type MGC and partial type MGC. In conclusion, we suggest that MGC was more frequently diagnosed in advanced stage than NMGC with a poorer prognosis and that it is reasonable to consider the carcinoma with mucin content involving more than 30% of the tumor area as MGC.  (+info)

(4/804) Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas.

PURPOSE: To comprehensively characterize the clinical and biologic features of tubular and mucinous carcinomas in a large cohort of patients and to relate this to clinical outcome and management. PATIENTS AND METHODS: The clinical and biologic features of 444 patients with tubular and 1,221 patients with mucinous carcinomas were compared with those of 43,587 patients with infiltrating ductal carcinoma, not otherwise specified (NOS). Disease-free survival (DFS) and overall survival (OS) for patients with tubular and mucinous carcinomas were compared with those of patients with NOS carcinomas and with age-matched sets from the general population. RESULTS: Tubular and mucinous carcinomas were more likely to occur in older patients, be smaller in size (tubular only), have substantially less nodal involvement, be estrogen receptor- and progesterone receptor-positive, have a lower S-phase fraction, be diploid, and be c-erbB-2- and epidermal growth factor receptor-negative compared with NOS carcinomas. Axillary node involvement was a poor prognostic feature in mucinous but not tubular carcinomas. Mucinous carcinomas < or = 1 cm had a < or = 5% incidence of node involvement. The 5-year DFS and OS were 94% and 88% for tubular, 90% and 80% for mucinous, and 80% and 77% for NOS carcinoma, respectively (P < .001 for differences among all three types for both DFS and OS). The 5-year OS of females from the general population age-matched to the patients with tubular and mucinous carcinomas was 89% and 82%, respectively, which is not different from the OS of patients with tubular or mucinous carcinomas. CONCLUSION: The biologic phenotype of tubular and mucinous carcinomas is quite favorable. Consistent with this observation, the survival of patients with tubular and mucinous carcinomas is similar to that of the general population. Systemic adjuvant therapy and node dissection may be avoided in many patients with these special types of carcinoma.  (+info)

(5/804) Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: correlation with up-regulation in epithelial ovarian cancer.

Abnormalities in the function of receptor tyrosine kinases (RTKs) have been demonstrated to be important in the pathogenesis of cancer. H-Ryk, a new member of the RTK family, is an unusual RTK in that it is catalytically inactive because of amino acid substitutions of conserved residues in the catalytic domain. We show by immunohistochemistry that it is expressed in the epithelium, stroma, and blood vessels of normal tissues. Evaluation of a panel of 33 primary ovarian tumors (2 benign, 8 borderline, and 23 malignant) was performed. H-Ryk was overexpressed in borderline and malignant ovarian tumors. In serous and clear cell subtypes, there was increased expression in the epithelium, stroma, and blood vessels. Consistent with this observation, overexpression of H-Ryk in the mouse fibroblast cell line NIH3T3 induces anchorage-independent growth and tumorigenicity in nude mice. This implies that overexpression of the receptor can be transforming and may therefore be significant in the pathogenesis of ovarian cancer.  (+info)

(6/804) Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.

The generation of vascular stroma is essential for solid tumor growth and involves stimulatory and inhibiting factors as well as stromal components that regulate functions such as cellular adhesion, migration, and gene expression. In an effort to obtain a more integrated understanding of vascular stroma formation in breast carcinoma, we examined expression of the angiogenic factor vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF); the VPF/VEGF receptors flt-1 and KDR; thrombospondin-1, which has been reported to inhibit angiogenesis; and the stromal components collagen type I, total fibronectin, ED-A+ fibronectin, versican, and decorin by mRNA in situ hybridization on frozen sections of 113 blocks of breast tissue from 68 patients including 28 sections of breast tissue without malignancy, 18 with in situ carcinomas, 56 with invasive carcinomas, and 8 with metastatic carcinomas. A characteristic expression profile emerged that was remarkably similar in invasive carcinoma, carcinoma in situ, and metastatic carcinoma, with the following characteristics: strong tumor cell expression of VPF/VEGF; strong endothelial cell expression of VPF/VEGF receptors; strong expression of thrombospondin-1 by stromal cells and occasionally by tumor cells; and strong stromal cell expression of collagen type I, total fibronectin, ED-A+ fibronectin, versican, and decorin. The formation of vascular stroma preceded invasion, raising the possibility that tumor cells invade not into normal breast stroma but rather into a richly vascular stroma that they have induced. Similarly, tumor cells at sites of metastasis appear to induce the vascular stroma in which they grow. We conclude that a distinct pattern of mRNA expression characterizes the generation of vascular stroma in breast cancer and that the formation of vascular stroma may play a role not only in growth of the primary tumor but also in invasion and metastasis.  (+info)

(7/804) Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.

The cyclin-dependent kinase inhibitors (CDIs) p27kip1 and p21waf1/cip1 are key cell cycle-negative regulatory enzymes. The objective of this study was to correlate expression of p27kip1 and p21waf1/cip1 with survival, chemotherapy responsiveness, and expression of the proliferation marker Ki-67 in patients with advanced colorectal cancer. Immunohistochemistry was performed with antibodies to p27kip1, p21waf1/cip1, and Ki-67 on samples from 66 patients with metastatic colorectal carcinoma. Interpretation was performed by visual inspection and automated image analysis. Patients who obtained a response to chemotherapy had greater p21waf1/cip1 tumor staining with a mean of 10.0 positive cells/high-powered field, compared with 4.5 positive cells/high-powered field for nonresponders (P = 0.03). A positive Spearman correlation was seen between Ki-67 and p27kip1 (r = 0.48; P = 0.0001), as well as between Ki-67 and p21waf1/cip1 (r = 0.48; P = 0.0001). A trend toward shorter survival was seen in patients with positive specimens (median survival of 10 months for patients with both p27kip1- and p21waf1/cip1-positive specimens, compared with 22 months for patients with neither p27kip1- nor p21waf1/cip1-positive specimens). In contrast to that previously reported in normal colonic mucosa or early-stage colorectal cancer, we observed positive correlations of Ki-67 with both p27kip1 and p21waf1/cip1, a trend toward greater CDI staining indicating worse prognosis, and greater p21waf1/cip1 staining in tumors that were chemosensitive. These findings suggest that in the metastatic setting, CDIs may show altered function, compared with their role in the normal cell cycle.  (+info)

(8/804) Carcinoma of the axillary breast.

Axillary breast is one of the varieties of polymastia which is characterized by the presence of more than 2 breasts. It may cause symptoms during pregnancy, lactation, or in the premenopausal period. Unless there are obvious symptoms of lactation or the assistance of further imaging studies such as mammography and breast ultrasound, the diagnosis is often confused with subcutaneous lipoma. The incidence of axillary breast cancer is low but it should be investigated and treated properly in view of another breast cancer in the embryonic milk-line. In this paper we reviewed 4 cases of axillary breast cancer and documented some articles regarding aberrant breast and carcinoma arising from it. It is suggested that subcutaneous nodules of uncertain origin around the periphery of the breast should be viewed with suspicion and treated properly.  (+info)

*  Pseudomyxoma peritonei
... several mucinous tumors (mucinous adenocarcinoma, mucinous cystadenoma, and mucinous cystadenocarcinoma), as well as other ... Low-grade mucinous adenocarcinoma is used by the American Joint Committee on Cancer and World Health Organization and is nearly ... The term mucinous adenocarcinoma is used in different contexts depending on the reference material used by the pathologist for ... For low-grade mucinous adenocarcinoma, disease may be designated as "benign" because tumors do not invade deeply into tissue ...
*  Primary cutaneous adenoid cystic carcinoma
Aggressive digital papillary adenocarcinoma Mucinous carcinoma Skin lesion James, William D.; Berger, Timothy G.; et al. (2006 ...
*  Keratin 7
Mucinous adenocarcinoma of the urachus synchronic with colorectal adenocarcinoma. Value of immunohistochemistry in the ...
*  Colorectal cancer
This occurs in mucinous adenocarcinoma, in which cells are poorly differentiated. If the mucus remains inside the tumor cell, ... Adenocarcinoma is a malignant epithelial tumor, originating from superficial glandular epithelial cells lining the colon and ... "Moderately differentiated adenocarcinoma (colon)". pathologyatlas.ro. Archived from the original on January 26, 2016. Sostres C ... The most common form of colon cancer is adenocarcinoma (98% of cases). Other, rarer types include lymphoma, adenosquamous and ...
*  CHST5
... in colonic mucinous adenocarcinoma". Glycobiology. 12 (6): 379-88. doi:10.1093/glycob/12.6.379. PMID 12107080. Akama TO, Misra ...
*  Endocarditis
NBTE may also occur in patients with cancers, particularly mucinous adenocarcinoma where Trousseau syndrome can be encountered ...
*  GAL3ST2
... expression in human colonic non-mucinous adenocarcinoma". Jpn. J. Cancer Res. 93 (5): 507-15. doi:10.1111/j.1349-7006.2002. ...
*  Trousseau sign of malignancy
... interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas". J ... Some adenocarcinomas secrete mucin that can interact with selectin found on platelets, thereby causing small clots to form. In ... Some malignancies, especially gliomas (25%), as well as adenocarcinomas of the pancreas and lung, are associated with ...
*  Microglandular hyperplasia
... a form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix". Int J Gynecol Pathol. 16 ... These features however are not characteristic exclusively to MGH, often being present in adenocarcinoma-affected tissue as well ... Zaloudek C, Hayashi GM, Ryan IP, Powell CB, Miller TR (1997). "Microglandular adenocarcinoma of the endometrium: ... of Morphologic and Immunohistochemical Features of Cervical Microglandular Hyperplasia with Low-grade Mucinous Adenocarcinoma ...
*  KRAS
The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ... Chiosea SI, Sherer CK, Jelic T, Dacic S (December 2011). "KRAS mutant allele-specific imbalance in lung adenocarcinoma". Modern ... "KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib". PLOS Medicine. 2 (1): e17. doi: ... "Mutant allele-specific imbalance modulates prognostic impact of KRAS mutations in colorectal adenocarcinoma and is associated ...
*  Surface epithelial-stromal tumor
... see mucinous adenocarcinoma with clinical condition Pseudomyxoma peritonei). Clear stromal invasion is used to differentiate ... As primary ovarian mucinous tumors are usually unilateral (in one ovary), the presentation of bilateral mucinous tumors ... of primary mucinous tumors are bilateral. May form very large cystic masses, with recorded weights exceeding 25 kg Mucinous ... Mucinous tumors: Closely resemble their serous counterparts but unlikely to be bilateral Somewhat less common, accounting for ...
*  Mucinous cystadenoma
Mucinous adenocarcinoma Grubor, NM.; Colovic, RB.; Atkinson, HD.; Micev, MT. (2013). "Giant biliary mucinous cystadenoma of the ... Mucinous cystadenomas may be found in the: Ovary - ovarian mucinous cystadenoma Pancreas - pancreatic mucinous cystadenoma ... mucinous cystadenoma of the liver Vermiform appendix - appendiceal mucinous cystadenoma (see cystadenoma) Mucinous cystadenomas ... Mucinous cystadenoma is a benign cystic tumor lined by a mucinous epithelium. It is a type of cystic adenoma (cystadenoma). ...
*  Ovarian cancer
Mucinous tumors include mucinous adenocarcinoma and mucinous cystadenocarcinoma. Mucinous adenocarcinomas make up 5-10% of ... Advanced mucinous adenocarcinomas have a poor prognosis, generally worse than serous tumors, and are often resistant to ... Low-grade serous adenocarcinomas resemble Fallopian tube epithelium, whereas high-grade serous adenocarcinomas show anaplasia ... Clear-cell adenocarcinomas are histopathologically similar to other clear cell carcinomas, with clear cells and hobnail cells. ...
*  Ferdinand I of Naples
The cause of his death was determined, in 2006, to have been colorectal cancer (mucinous adenocarcinoma type with mutation in ...
*  Endometrial cancer
Mucinous carcinomas must be differentiated from cervical adenocarcinoma. Mixed carcinomas are those that have both Type I and ... Some endometrioid adenocarcinomas have foci of mucinous carcinoma. The genetic mutations most commonly associated with ... Mucinous endometrial carcinomas are most often stage I and grade I, giving them a good prognosis. They typically have well- ... An MRI can be of some use in determining if the cancer has spread to the cervix or if it is an endocervical adenocarcinoma. MRI ...
*  Hyperthermic intraperitoneal chemotherapy
It is also used for: mucinous adenocarcinoma (MAC) of appendix mesothelioma low-grade sarcoma Various chemotherapies are used ...
*  List of MeSH codes (C04)
... mucinous, and serous MeSH C04.557.470.590.075 --- adenocarcinoma, mucinous MeSH C04.557.470.590.340 --- carcinoma, ... adenocarcinoma, mucinous MeSH C04.557.470.200.025.085 --- adenocarcinoma, papillary MeSH C04.557.470.200.025.085.225 --- ... adenocarcinoma, bronchiolo-alveolar MeSH C04.557.470.200.025.045 --- adenocarcinoma, clear cell MeSH C04.557.470.200.025.060 ... mucinous MeSH C04.557.470.035.320.230 --- cystadenoma, papillary MeSH C04.557.470.035.320.240 --- cystadenoma, serous MeSH ...
*  Salivary gland tumour
... carcinoma Sebaceous lymphadenocarcinoma Cystadenocarcinoma Low-grade cribriform cystadenocarcinoma Mucinous adenocarcinoma ... Oncocytic carcinoma Salivary duct carcinoma Salivary duct carcinoma, not otherwise specified Adenocarcinoma, not otherwise ... epithelial tumors Acinic cell carcinoma Mucoepidermoid carcinoma Adenoid cystic carcinoma Polymorphous low-grade adenocarcinoma ... Epithelial-myoepithelial carcinoma Clear cell carcinoma, not otherwise specified Basal cell adenocarcinoma Sebaceous ...
*  Appendix (anatomy)
Mucinous adenocarcinoma of the appendix tip Cross section of the appendix with Enterobius with H&E stain Histology of vermiform ...
*  Adolf Gusserow
... or as a mucinous type of "minimal deviation adenocarcinoma" (mucinous MDA). It can be recognized by its "deceptively bland" ... In 1870 Gusserow was the first physician to describe a rare type of uterine cervical adenocarcinoma that is sometimes referred ...
*  Stomach cancer
Diffuse type adenocarcinoma (mucinous, colloid, linitis plastica or leather-bottle stomach) tumour cells are discohesive and ... Stomach cancers are overwhelmingly adenocarcinomas (90%). Histologically, there are two major types of gastric adenocarcinoma ( ... Adenocarcinomas tend to aggressively invade the gastric wall, infiltrating the muscularis mucosae, the submucosa and then the ... Obesity is a physical risk factor that has been found to increase the risk of gastric adenocarcinoma by contributing to the ...
*  Large-cell lung carcinoma with rhabdoid phenotype
... mucinous adenocarcinomas (particularly those featuring signet-ring cells), rhabdomyosarcoma, epitheloid angiosarcoma, pleural ... adenocarcinomas with rhabdoid features have been reported to have worse prognoses than adenocarcinomas without rhabdoid ... Sheikh SS, Al-Khatti AA, Amr SS (February 2008). "Metachronus malignant rhabdoid tumor of the ileum and adenocarcinoma of lung ... Song DE, Jang SJ, Black J, Ro JY (September 2007). "Mucinous bronchioloalveolar carcinoma of lung with a rhabdoid component- ...
*  CD133
"CD133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas". ...
*  Mucinous cystadenocarcinoma of the lung
... mucinous bronchioloalveolar carcinoma, signet ring cell adenocarcinoma, mucinous cystadenocarcinoma, and mucinous "colloid" ... pseudomyxomatous pulmonary adenocarcinoma, mucinous cystic tumor of low malignant potential, and others. According to the most ... solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence ... may be of use in differentiating primary mucinous cystadenocarcinoma of the lung from metastatic lung tumors due to mucinous ...
*  Hereditary nonpolyposis colorectal cancer
... right-sided poorly differentiated cancers right-sided mucinous cancers adenocarcinomas in any location showing any measurable ... In HNPCC, the mean age of diagnosis of gastric cancer is 56 years of age with intestinal-type adenocarcinoma being the most ...
*  Signet ring cell carcinoma
... rate of patients with SRCC was significantly poorer than that of patients with mucinous or poorly differentiated adenocarcinoma ... When compared to adenocarcinoma stomach, SRCC in the stomach occurs more often in women and younger patients. Patients with ... Highly differentiated adenocarcinomas form SRCCs via a loss of adherens and tight junctions that typically separate MUC4, a ... "Mucinous and Signet-Ring Cell Colorectal Cancers Differ from... : Annals of Surgery". LWW. Retrieved 2016-04-20. Takashi ...
Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma  Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma
Primary pulmonary mucinous adenocarcinoma (PPMA) is an uncommon subtype of lung adenocarcinoma. The present study attempted to ... The majority of mucinous adenocarcinomas expressed thyroid transcription factor 1, Napsin A, Villin and Cam5.2 proteins. KRAS ... Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma. *Authors: *Fei Sun ... of patients and were more prevalent in the lower lung lobe and in patients with invasive mucinous adenocarcinoma. A total of 2 ...
more infohttps://www.spandidos-publications.com/ol/15/1/489/abstract
JAIRO | Complete Response of Advanced Invasive Mucinous Adenocarcinoma of the Lung with Gemcitabine and Pemetrexed  JAIRO | Complete Response of Advanced Invasive Mucinous Adenocarcinoma of the Lung with Gemcitabine and Pemetrexed
Complete Response of Advanced Invasive Mucinous Adenocarcinoma of the Lung with Gemcitabine and PemetrexedComplete Response of ... Advanced Invasive Mucinous Adenocarcinoma of the Lung with Gemcitabine and PemetrexedAN00120815. ...
more infohttp://jairo.nii.ac.jp/0028/00018763/en
v.10, n.3, 6 - Intestinal mucinous adenocarcinoma with metastases to epididymis, testis and tunica albuginea in a dog - BJVP -...  v.10, n.3, 6 - Intestinal mucinous adenocarcinoma with metastases to epididymis, testis and tunica albuginea in a dog - BJVP -...
Guerra Abstract A case of intestinal mucinous adenocarcinoma with metastasis to gonadal tissue is reported. A 13-year-old, male ... 6 Case Report Intestinal mucinous adenocarcinoma with metastases to epididymis, testis and tunica albuginea in a dog Danilo G. ... You Are Here: Home » Banner » v.10, n.3, 6 - Intestinal mucinous adenocarcinoma with metastases to epididymis, testis and ... Intestinal mucinous adenocarcinoma with metastases to epididymis, testis and tunica albuginea in a dog. Danilo G. Wasques, ...
more infohttp://bjvp.org.br/banner/2017/11/v-10-n-3-6-intestinal-mucinous-adenocarcinoma-metastases-epididymis-testis-tunica-albuginea-dog/
A rare case of invasive mucinous adenocarcinoma of fallopian tube fimb by S. X. Liang, T. C. Brandler et al.  "A rare case of invasive mucinous adenocarcinoma of fallopian tube fimb" by S. X. Liang, T. C. Brandler et al.
Here we report a moderately differentiated mucinous adenocarcinoma arising in the tubal fimbria in a 70-year-old woman. Patient ... we concluded that this tumor most likely represented a mucinous adenocarcinoma of tubal origin. ... In addition, the non-tumorous fimbria epithelium showed a spectrum of mucinous alterations with variable nuclear atypia: ... Frozen section and final pathology diagnosis revealed moderately differentiated adenocarcinoma arising in the left fimbria. ...
more infohttps://academicworks.medicine.hofstra.edu/articles/706/
Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique) | Guidance and guidelines | NICE  Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique) | Guidance and guidelines | NICE
... mucinous adenocarcinoma). However, not all patients in this study were followed up for 5 years, and it is not clear how ...
more infohttps://www.nice.org.uk/guidance/ipg56/chapter/2-The-procedure
Clinicopathologic characteristics of teenage sporadic colorectal cancer  Clinicopathologic characteristics of teenage sporadic colorectal cancer
With respect to histologic type, adenocarcinoma represented 57.8% of cases, mucinous adenocarcinoma, 31.5%, and signet ring ... had mucinous adenocarcinoma and signet ring cell type. In contrast, the patients with adenocarcinoma had a mortality rate of ... adenocarcinoma was identified in 11 cases (57.8%), mucinous adenocarcinoma in 6 cases (31.5%), and signet ring cell type in 2 ... adenocarcinoma is the most common type, being found in 85% of adult CRC patients, followed by mucinous adenocarcinoma (10%-15 ...
more infohttp://www.kjco.org/journal/view.php?number=280
Eccrine Mucinous Carcinoma  Eccrine Mucinous Carcinoma
Papillary Adenocarcinoma; Primary Cutaneous Mucinous Carcinoma; Refractory Anaplastic Large Cell Lymphoma; Refractory Mature T- ... Mucinous eccrine carcinoma (MEC) is a rare malignant tumor that typically arises in the periorbital area. ... Finding the right clinical trial for Eccrine Mucinous Carcinoma can be challenging. However, with TrialsFinder (which uses the ... The terms "Eccrine Mucinous Carcinoma" returned 0 free, full-text research articles on human participants. ...
more infohttp://www.diseaseinfosearch.org/result/2434
Primary Villoglandular Mucinous Adenocarcinoma of the Vulva  Primary Villoglandular Mucinous Adenocarcinoma of the Vulva
... Akiko Matsuzaki,1,2 Masanao Saio,1,2 Noritake Kosuge,1,2 Hajime ... Primary villoglandular mucinous adenocarcinoma of the vulva is rare tumor. We report a case of 68-year-old woman who developed ...
more infohttps://www.hindawi.com/journals/cripa/2017/1765460/abs/
Colon Mucinous Adenocarcinoma in Childhood: A Case Report with Emphasis on Image Findings  Colon Mucinous Adenocarcinoma in Childhood: A Case Report with Emphasis on Image Findings
... Antonio Muccillo, Edson Marchiori, ... and subsequent histopathologic analysis revealed a colon mucinous adenocarcinoma. ...
more infohttps://www.hindawi.com/journals/crim/2010/327634/abs/
Mucinous adenocarcinoma of the appendix | Radiology Reference Article | Radiopaedia.org  Mucinous adenocarcinoma of the appendix | Radiology Reference Article | Radiopaedia.org
For the mucinous carcinomas involving the remainder of the colon, please refer to the article on mucino... ... Mucinous adenocarcinomas of the appendix are on the malignant end of the spectrum of the mucinous neoplasms that affect the ... Mucinous adenocarcinomas of the appendix are on the malignant end of the spectrum of the mucinous neoplasms that affect the ... An adenocarcinoma is defined as mucinous when extracellular mucin corresponds to more than 50% of the lesion. The signet ring ...
more infohttps://radiopaedia.org/articles/mucinous-adenocarcinoma-of-the-appendix-1
Mucinous Adenocarcinoma of the Ileal Neobladder 20 Years After Cystectomy: The First Reported Case  Mucinous Adenocarcinoma of the Ileal Neobladder 20 Years After Cystectomy: The First Reported Case
The authors present the case of a 68-year-old male with mucinous adenocarcinoma of the ileal neobladder. The adenocarcinoma ... Mucinous Adenocarcinoma of the Ileal Neobladder 20 Years After Cystectomy: The First Reported Case .utlogo1 { display: none ! ... He developed mucinous adenocarcinoma with villous adenoma in the ileal pouch 20 years later. This appears to be the first ... However, the present authors did not find any previous report of mucinous adenocarcinoma arising in an ileal pouch after ...
more infohttps://www.urotoday.com/volume-2-2009/vol-2-issue-6/33120-mucinous-adenocarcinoma-of-the-ileal-neobladder-20-years-after-cystectomy-the-first-reported-case-2226036.html
A Giant Mucinous Adenocarcinoma Arising within a Villous Adenoma of the Urachus: Case Report and Review of the Literature.  A Giant Mucinous Adenocarcinoma Arising within a Villous Adenoma of the Urachus: Case Report and Review of the Literature.
... consisting of both villous adenoma and mucinous adenocarcinoma of the urachus. The tumor was incidentally discovered during ... Mucinous adenocarcinoma of the urinary bladderJournal of UrologyYear: 19551196871. 3. Herr HW. Urachal carcinoma: the case for ... A Giant Mucinous Adenocarcinoma Arising within a Villous Adenoma of the Urachus: Case Report and Review of the Literature ... Mucinous papillary adenocarcinoma of the bladder arising within villous adenoma of urachal remnants. An Immunohistochemical and ...
more infohttp://www.biomedsearch.com/nih/Giant-Mucinous-Adenocarcinoma-Arising-within/20182635.html
Prognostic significance and molecular features of colorectal mucinous adenocarcinomas : A strobe-compliant study  Prognostic significance and molecular features of colorectal mucinous adenocarcinomas : A strobe-compliant study
Mucinous adenocarcinoma (MC) is a special histology subtype of colorectal adenocarcinoma. The survival of MC is controversial ... Prognostic significance and molecular features of colorectal mucinous adenocarcinomas: A strobe-compliant study. Wang, Mo-Jin ... MC was more frequently localized in the right colon compared with nonmucinous adenocarcinoma (NMC) in both SEER (57.7% vs 37.2 ...
more infohttp://oru.diva-portal.org/smash/record.jsf?pid=diva2:909019
Prognosis of Mucinous Adenocarcinoma of the Prostate Treated by Radical Prostatectomy: A Study of 47 Cases  Prognosis of Mucinous Adenocarcinoma of the Prostate Treated by Radical Prostatectomy: A Study of 47 Cases
We present 47 cases (1991 to 2006) of mucinous carcinomas treated by radical prostatectomy. Mean patient age at diagnosis was ... Mucinous adenocarcinoma of the prostate is one of the least common variants of prostate cancer. The prognosis of this variant ... Prognosis of Mucinous Adenocarcinoma of the Prostate Treated by Radical Prostatectomy: A Study of 47 Cases ... Mucinous adenocarcinoma of the prostate is one of the least common variants of prostate cancer. The prognosis of this variant ...
more infohttps://insights.ovid.com/crossref?an=00000478-200803000-00016
John Libbey Eurotext - European Journal of Dermatology - Perianal Paget disease secondary to pagetoid spread of mucinous...  John Libbey Eurotext - European Journal of Dermatology - Perianal Paget disease secondary to pagetoid spread of mucinous...
Perianal Paget disease secondary to pagetoid spread of mucinous adenocarcinoma of the anal canal Volume 28, issue 2, March- ... Perianal Paget disease secondary to pagetoid spread of mucinous adenocarcinoma of the anal canal ...
more infohttp://www.jle.com/en/revues/ejd/e-docs/perianal_paget_disease_secondary_to_pagetoid_spread_of_mucinous_adenocarcinoma_of_the_anal_canal_311312/article.phtml
Human-Stomach poor differentiated mucinous adenocarcinoma, partly signet-ring cell carcinoma tissue section slide (paraffin...  Human-Stomach poor differentiated mucinous adenocarcinoma, partly signet-ring cell carcinoma tissue section slide (paraffin...
Human-Stomach poor differentiated mucinous adenocarcinoma, partly signet-ring cell carcinoma tissue section slide (paraffin ... Home » Tissue Slides » Human-Stomach poor differentiated mucinous adenocarcinoma, partly signet-ring cell carcinoma tissue ... S0461 Human-Stomach poor differentiated mucinous adenocarcinoma, partly signet-ring cell carcinoma tissue section slide ( ... Properties for Human-Stomach poor differentiated mucinous adenocarcinoma, partly signet-ring cell carcinoma tissue section ...
more infohttps://www.acris-antibodies.com/tissue-slides/human-stomach-poor-differentiated-mucinous-adenocarcinoma-partly-signet-ring-cell-carcinoma-tissue-section-slide-paraffin-embedded-s0461.htm
Vitamin A contents of rat intestinal epithelium and jejunal mucinous adenocarcinoma. | Docphin  Vitamin A contents of rat intestinal epithelium and jejunal mucinous adenocarcinoma. | Docphin
Vitamin A contents of rat intestinal epithelium and jejunal mucinous adenocarcinoma. , Journal of the National Cancer Institute ... Vitamin A contents of rat intestinal epithelium and jejunal mucinous adenocarcinoma. P R Sundaresan L M De Luca 6/1/1977 ... Vitamin A contents of rat intestinal epithelium and jejunal mucinous adenocarcinoma. J Natl Cancer Inst. 1977;58(6):1643-5. ... The concentration of vitamin A per cell in the adenocarcinoma tissue was about 20 times less than that in intestinal epithelium ...
more infohttps://www.docphin.com/research/article-detail/16042175/PubMedID-194041/Vitamin-A-contents-of-rat-intestinal-epithelium-and-jejunal-mucinous-adenocarcinoma
anal mucinous adenocarcinoma 2005:2010[pubdate] *count=100 - BioMedLib™ search engine  anal mucinous adenocarcinoma 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
Adenocarcinoma, Mucinous / genetics. Adenocarcinoma, Mucinous / metabolism. Adenocarcinoma, Mucinous / pathology. ... Adenocarcinoma, Clear Cell / surgery. Adenocarcinoma, Mucinous / pathology. Adenocarcinoma, Mucinous / surgery. Adult. Aged. ... Adenocarcinoma / surgery. Adenocarcinoma, Mucinous / physiopathology. Adenocarcinoma, Mucinous / surgery. Age Factors. Aged. ... Title] Mucinous adenocarcinoma arising in an anorectal fistula.. * Mucinous adenocarcinoma in association with chronic anal ...
more infohttp://www.bmlsearch.com/?kwr=anal+mucinous+adenocarcinoma+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
Mucinous adenocarcinoma of colon - Bowtrol Colon Cleanser and Sensitive Digestion Support - Feb 8, 2018  Mucinous adenocarcinoma of colon - Bowtrol Colon Cleanser and Sensitive Digestion Support - Feb 8, 2018
Surgery and Hyperthermia for Mucinous Colorectal Cancer , Fight.... Bowtrol Colon Cleanser Health Support forumlas include ... Mucinous Adenocarcinoma , Mucinous Medical (https://mucinous.org/mucinous-adenocarcinoma/) Mucinous (colloid) adenocarcinoma ... Mucinous Adenocarcinoma , Mucinous Medical (http://mucinous.org/mucinous-adenocarcinoma/) Mucinous carcinoma is a type of ... Mucinous Adenocarcinoma , Mucinous Adenocarcinoma (http://www.mucinousadenocarcinoma.com/category/muci nous-adenocarcinoma) ...
more infohttp://bowtrol.herbalous.com/mucinous-adenocarcinoma-of-colon.html
Mucinous adenocarcinoma of the bladder associated with long term suprapubic tube: a case report | BMC Urology | Full Text  Mucinous adenocarcinoma of the bladder associated with long term suprapubic tube: a case report | BMC Urology | Full Text
The final diagnosis was a high-grade, T2a/N0/M0 (Stage II) mucinous adenocarcinoma of the bladder. There has been no evidence ... The final diagnosis was a high-grade, T2a/N0/M0 (Stage II) mucinous adenocarcinoma of the bladder based upon WHO/ISUP grading ... Mucinous adenocarcinoma arising from a suprapubic cystostomy site without bladder involvement. J Spinal Cord Med. 1997;20(2): ... In this case report, we present radiographic findings of a case of mucinous adenocarcinoma of the bladder and suprapubic (SP) ...
more infohttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-015-0112-8/
  • Frozen section and final pathology diagnosis revealed moderately differentiated adenocarcinoma arising in the left fimbria. (hofstra.edu)
  • Concentrations of retinol and tetinyl esters were assayed in rat intestinal mucosa and in chemically induced transplanted mucinous adenocarcinoma of the jejunum. (docphin.com)
  • The pathological diagnosis was ICPN, intestinal type, with an associated mucinous adenocarcinoma arising in RA sinus. (springeropen.com)
  • Immunohistochemistry was positive for CDX2 and pancytokeratin, and negative for vimentin, supporting the diagnosis of intestinal mucinous adenocarcinoma with metastases to epididymis, testis and tunica albuginea. (bjvp.org.br)
  • Casali C, Rossi G, Marchioni A, Sartori G, Maselli F, Longo L, Tallarico E and Morandi U: A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: Clinicopathologic analysis, molecular features and possible pitfalls in routine practice. (spandidos-publications.com)
  • An international literature search revealed 10 cases with a neoplasm in an ileocystoplasty, but this type of adenocarcinoma has not been reported previously. (urotoday.com)
  • Adenocarcinoma , Mucinous Signet Ring Type - SurgPath4U (http://www.surgpath4u.com/caseviewer.php%3Fcase_no% 3D295) A pale glistening right sided mass suggests the high content of mucin . (herbalous.com)